AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 52 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $31 | -35.4% | 105,800 | 0.0% | 0.00% | -40.0% |
Q4 2022 | $48 | -99.9% | 105,800 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $56,000 | +5.7% | 105,800 | 0.0% | 0.01% | +20.0% |
Q2 2022 | $53,000 | -78.2% | 105,800 | 0.0% | 0.01% | -75.0% |
Q1 2022 | $243,000 | -51.7% | 105,800 | 0.0% | 0.02% | -47.4% |
Q4 2021 | $503,000 | -39.0% | 105,800 | +2.1% | 0.04% | -45.7% |
Q3 2021 | $824,000 | +14.3% | 103,600 | 0.0% | 0.07% | +14.8% |
Q2 2021 | $721,000 | -12.2% | 103,600 | 0.0% | 0.06% | -19.7% |
Q1 2021 | $821,000 | +42.0% | 103,600 | +41.0% | 0.08% | +35.7% |
Q4 2020 | $578,000 | +10.9% | 73,500 | 0.0% | 0.06% | 0.0% |
Q3 2020 | $521,000 | +12.5% | 73,500 | +47.0% | 0.06% | +1.8% |
Q2 2020 | $463,000 | +184.0% | 50,000 | +42.9% | 0.06% | +129.2% |
Q1 2020 | $163,000 | -28.8% | 35,000 | +16.7% | 0.02% | -11.1% |
Q4 2019 | $229,000 | -0.9% | 30,000 | 0.0% | 0.03% | -6.9% |
Q3 2019 | $231,000 | +12.1% | 30,000 | 0.0% | 0.03% | +7.4% |
Q2 2019 | $206,000 | -14.9% | 30,000 | 0.0% | 0.03% | -20.6% |
Q1 2019 | $242,000 | +61.3% | 30,000 | +50.0% | 0.03% | +41.7% |
Q4 2018 | $150,000 | – | 20,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $891,000 | 15.31% |
Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
Abingworth LLP | 240,500 | $1,912,000 | 0.43% |